Accession | Acc. Gene-, Name | Start | End | Subsequence | Logic | PDB | Organism | Length |
---|---|---|---|---|---|---|---|---|
ELMI003957 | Q9UBT6 POLK POLK_HUMAN |
862 | 869 | STSKKIKPNNPKHTLDIFFK | TP |
2ZVL |
Homo sapiens (Human) | 870 |
Instance evidence
Evidence class | PSI-MI | Method | BioSource | PubMed | Logic | Reliability | Notes |
---|---|---|---|---|---|---|---|
experimental | MI:0114 | x-ray crystallography | in vitro | Hishiki,2009 | support | certain | InteractionDetection FeatureDetection |
Interactions
Uniprot Id | Domain family | Domain Start | Domain End | Affinity Min/Max (µMol) | Notes |
---|---|---|---|---|---|
(P12004) PCNA_HUMAN | PF02747
(PCNA_C)
Proliferating cell nuclear antigen, C-terminal domain |
127 | 254 | [mitab][xml] |
Pathways
KEGG: The sequence Q9UBT6 is implicated in the following 17 Pathways: (color codes: This sequence=red, interacting sequence=orange)- Basal cell carcinoma
- Breast cancer
- Chronic myeloid leukemia
- Colorectal cancer
- Endometrial cancer
- Epstein Barr virus infection
- Fanconi anemia pathway
- Gastric cancer
- Glioma
- Hepatocellular carcinoma
- Melanoma
- Non small cell lung cancer
- Pancreatic cancer
- Pathways in cancer
- Small cell lung cancer
- Thyroid cancer
- Transcriptional misregulation in cancer
Please cite:
ELM-the Eukaryotic Linear Motif resource-2024 update.
(PMID:37962385)
ELM data can be downloaded & distributed for non-commercial use according to the ELM Software License Agreement
ELM data can be downloaded & distributed for non-commercial use according to the ELM Software License Agreement